This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

OBR Peer-Spectives

By OBR Peer-Spectives

News, Perspective, Catalyst

  1. 1.
    Renal Cell Carcinoma (RCC) – Bradley McGregor, MD, and Robert Figlin, MD, discuss clinical highlights from ESMO 202010/27/2020
    10:19
  2. 2.
    Non Small Cell Lung Cancer – Victoria Villaflor, MD, and Robert Figlin, MD, discuss unresectable stage III NSCLC10/21/2020
    7:59
  3. 3.
    Gastric/GE Junction Cancer – Geoffrey Ku, MD, and Robert Figlin, MD, discuss recent clinical developments in gastric and esophageal cancer10/16/2020
    13:22
  4. 4.
    Breast Cancer – Sara Hurvitz, MD, and Robert Figlin, MD, discuss recent clinical developments in early stage and late stage breast cancer07/17/2020
    15:04
  5. 5.
    Breast Cancer – Nancy Lin, MD, and Robert Figlin, MD, discuss novel agents and recent clinical developments in breast cancer from ASCO2006/28/2020
    9:00
  6. 6.
    Adjuvant Lung Cancer – Roy Herbst, MD and Robert Figlin, MD discuss the recent ASCO20 plenary presentation of the ADAURA study investigating the use of Tagrisso (osimertinib) in the adjuvant setting for NSCLC EGFR+ patients06/25/2020
    10:41
  7. 7.
    Colon and Rectal Cancer – David Ilson, MD, and Robert Figlin, MD, discuss recent clinical advances in colon and rectal cancer from ASCO20 Virtual06/15/2020
    12:55
  8. 8.
    Non Small Cell Lung Cancer (NSCLC) – Edward Garon, MD, and Robert Figlin, MD, discuss promising agents in development for the management of NSCLC from ASCO2006/11/2020
    11:42

Listen to OBR Peer-Spectives now.

Listen to OBR Peer-Spectives in full in the Spotify app